10:05am ET
Health and Healthcare
Allergan Accepts Buyout Offer From Actavis, Valeant Bows Out
Botox maker Allergan has entered a definitive agreement to be acquired by Actavis, despite higher offer from Valeant Pharmaceuticals.
Companies
/Financial Services
Enact Holdings Inc
$49.04
▼ $0.17 (−0.35%) today
Markets closed · 8:44am ET
ACT Coverage
Page 2
8:30am ET
Investing
Deutsche Bank’s U.S. Stock Selection Best Buy Ideas
A new Deutsche Bank report from the firm's quantitative strategies team highlights the current best buy ideas.
8:15am ET
Health and Healthcare
Analyst’s Top 4 Specialty Pharmaceutical Stocks to Buy Before Earnings
The analysts at Piper Jaffray are very positive on four top specialty pharmaceutical stocks with potential for a strong fourth-quarter rally in their shares.
10:05am ET
Health and Healthcare
3 Irish Specialty Pharmaceutical Stocks to Buy After Tax Inversion Implosion
A new research report from Merrill Lynch features three top pharmaceutical companies, dubbed the “Irish 3-Pack.”
8:37am ET
Investing
Top Analyst Upgrades and Downgrades: AECOM, Intercept, Kinder Morgan, Rackspace, SunEdison, Disney and More
Jon OggStocks were holding on to small gains on Tuesday even after weaker sentiment was reported out of Europe. It looks as though investors have decided they can now shop around for…
8:20am ET
Investing
Top Analyst Upgrades and Downgrades: Alcoa, Cigna, Intel, Molina, Teva, UnitedHealth and More
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Friday, June 27, 2014. They include Alcoa, Cigna, Intel, Molina Healthcare, Teva Pharmaceutical and UnitedHealth.
10:59am ET
Investing
Best Five Stocks Over $100
ThinkstockThere are 84 stocks in the Standard & Poor’s 500 Index which trade for more than $100 a share. The best known are Google Inc. (NASDAQ: GOOG) and Apple Inc. (NASDAQ: AAPL), However, they…
11:05am ET
Health and Healthcare
Why Teva May Be Back From the Dead
Two analyst upgrades on Friday, a new CEO and a 33% increase in its stock price since November may be confirmation that Teva Pharmaceutical Industries is finally rebounding. Analysts think the stock…
9:00am ET
Health and Healthcare
Biotech Stocks to Buy After the Pullback
The biotech and specialty pharmaceutical groups got hit hard Thursday for a variety of reasons. The largest of which the analysts at Jefferies believe, is commentary within Washington's new budget proposal regarding…
8:20am ET
Investing
Top Analyst Upgrades and Downgrades: Analog Devices, Chelsea Therapeutics, Tesla, Westport, More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday February 19, 2014. They include Analog Devices, Chelsea Therapeutics, Tesla Motors and Westport Innovations .
4:01pm ET
Investing
The 4 Stocks That Dominated the Market on Tuesday
thinkstockFebruary 18, 2014: Markets opened slightly higher on Monday but the DJIA turned south quickly and struggled all day before finishing with a fractional loss. The healthcare sector, especially in the biotech…
8:15am ET
Investing
UBS Live Key Call List Features the Top Nine Stocks to Buy Now
Frank Golhen, via Wikimedia CommonsAt the beginning of the year, we presented the lists from most major Wall Street firms of their top stocks to buy for the year. After one of…
4:07pm ET
Investing
Closing Bell for Friday on Wall Street: Markets Open Mixed, Close Higher
U.S. equity markets opened mixed this morning and failed to find a direction driver throughout the trading day. In Europe, Germany reported a stronger-than-expected trade surplus, while the U.K.’s trade deficit was…
8:35am ET
Investing
Bank of America Merrill Lynch Unveils Secular Growth Stock Buy List (BAC, PETM, HLF, MYGN, ACT, SAH, HEI, FEIC, LOPE)
The negative fourth-quarter gross domestic product (GDP) reading of -0.1% caught most Wall St. analysts and economists by surprise. This unforeseen number was skewed by a huge decrease in government spending. Most…